In hematopoietic stem and progenitor cells (HSPCs) obtained from two mouse models incorporating two common class I mutations observed in human AML, FLT3-ITD and NrasG12D, IDH2R140Q or IDH2R172K mutations conferred inferior overall survival and drive aggressive AML. The gene discussed is FLT3; the disease is acute myeloid leukemia.